JP2020055766A - デュタステリドを含有する軟カプセル剤 - Google Patents

デュタステリドを含有する軟カプセル剤 Download PDF

Info

Publication number
JP2020055766A
JP2020055766A JP2018186531A JP2018186531A JP2020055766A JP 2020055766 A JP2020055766 A JP 2020055766A JP 2018186531 A JP2018186531 A JP 2018186531A JP 2018186531 A JP2018186531 A JP 2018186531A JP 2020055766 A JP2020055766 A JP 2020055766A
Authority
JP
Japan
Prior art keywords
capsule
mass
dutasteride
content
less
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018186531A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020055766A5 (https=
Inventor
高橋　雅人
Masato Takahashi
雅人 高橋
後藤　正浩
Masahiro Goto
正浩 後藤
遠藤　隆浩
Takahiro Endo
隆浩 遠藤
愛 佐野
Ai Sano
愛 佐野
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyo Capsule Co Ltd
Original Assignee
Toyo Capsule Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyo Capsule Co Ltd filed Critical Toyo Capsule Co Ltd
Priority to JP2018186531A priority Critical patent/JP2020055766A/ja
Publication of JP2020055766A publication Critical patent/JP2020055766A/ja
Publication of JP2020055766A5 publication Critical patent/JP2020055766A5/ja
Pending legal-status Critical Current

Links

Images

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2018186531A 2018-10-01 2018-10-01 デュタステリドを含有する軟カプセル剤 Pending JP2020055766A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2018186531A JP2020055766A (ja) 2018-10-01 2018-10-01 デュタステリドを含有する軟カプセル剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2018186531A JP2020055766A (ja) 2018-10-01 2018-10-01 デュタステリドを含有する軟カプセル剤

Publications (2)

Publication Number Publication Date
JP2020055766A true JP2020055766A (ja) 2020-04-09
JP2020055766A5 JP2020055766A5 (https=) 2020-07-02

Family

ID=70106403

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018186531A Pending JP2020055766A (ja) 2018-10-01 2018-10-01 デュタステリドを含有する軟カプセル剤

Country Status (1)

Country Link
JP (1) JP2020055766A (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021172663A (ja) * 2020-04-21 2021-11-01 東和薬品株式会社 ルビプロストンを含む軟カプセル剤及びその製造方法

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS574267B2 (https=) * 1979-04-18 1982-01-25
JPS61186314A (ja) * 1985-02-13 1986-08-20 Nippon Eranko Kk 易溶性硬質ゼラチンカプセル
CN1634427A (zh) * 2004-11-01 2005-07-06 辽宁大生药业有限公司 三黄软胶囊及其制备工艺
JP2007124918A (ja) * 2005-11-01 2007-05-24 Q P Corp ソフトカプセル
WO2014002015A1 (en) * 2012-06-25 2014-01-03 Ranbaxy Laboratories Limited Pharmaceutical composition comprising dutasteride
WO2014147096A1 (en) * 2013-03-19 2014-09-25 Galenicum Health S.L. Pharmaceutical compositions comprising an active agent
JP2016514724A (ja) * 2013-06-28 2016-05-23 ハンミ ファーム． シーオー．， エルティーディー． デュタステリドを含む経口軟カプセル製剤

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS574267B2 (https=) * 1979-04-18 1982-01-25
JPS61186314A (ja) * 1985-02-13 1986-08-20 Nippon Eranko Kk 易溶性硬質ゼラチンカプセル
CN1634427A (zh) * 2004-11-01 2005-07-06 辽宁大生药业有限公司 三黄软胶囊及其制备工艺
JP2007124918A (ja) * 2005-11-01 2007-05-24 Q P Corp ソフトカプセル
WO2014002015A1 (en) * 2012-06-25 2014-01-03 Ranbaxy Laboratories Limited Pharmaceutical composition comprising dutasteride
WO2014147096A1 (en) * 2013-03-19 2014-09-25 Galenicum Health S.L. Pharmaceutical compositions comprising an active agent
JP2016514724A (ja) * 2013-06-28 2016-05-23 ハンミ ファーム． シーオー．， エルティーディー． デュタステリドを含む経口軟カプセル製剤

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021172663A (ja) * 2020-04-21 2021-11-01 東和薬品株式会社 ルビプロストンを含む軟カプセル剤及びその製造方法
JP7678698B2 (ja) 2020-04-21 2025-05-16 東和薬品株式会社 ルビプロストンを含む軟カプセル剤及びその製造方法

Similar Documents

Publication Publication Date Title
TW529951B (en) Pharmaceutical composition comprising a 2- [[(2-pyridinyl) methyl]sulfinyl]benzimidazole having anti-ulcer activity and a process for the preparation of such pharmaceutical composition
CA2724533C (en) Stabilized atypical antipsychotic formulation
TWI354569B (en) Coated tablet formulation and method
EP3653203A1 (en) Enteric hard capsule
HU206044B (en) Process for producing compositions with controlled release of dihydropyridine derivatives as active ingredient
EP2772250A1 (en) Enteric composition for the manufacture of soft capsule wall
JP4652052B2 (ja) 錠剤及びカプレットのためのフィルムコーティング
JP2021138762A (ja) 経口フィルム製剤
WO1992017166A1 (fr) Gelule
TW201249479A (en) Controlled release hydrogel formulation
WO2019149917A1 (en) A pharmaceutical composition comprising metamizole, drotaverine, and caffeine
JPH05178747A (ja) ジルチアゼム処方剤
JP2019500416A (ja) デュタステリド及びプロピレングリコールモノラウレートを含有する医薬組成物及びその調製方法
WO1996032097A1 (fr) Compositions solides contenant du polyethyleneoxyde et un principe actif non amorphe
JP2009512699A (ja) 遅延放出とその後の持続放出の腸溶性を有する液体剤形
WO2007044488A1 (en) Enteric soft capsule comprising valproic acid
EP2384745A2 (en) Modified Release Pharmaceutical Compositions Of Dexlansoprazole
TW201127816A (en) 4-methylpyrazole formulations
JP2020055766A (ja) デュタステリドを含有する軟カプセル剤
JP2024515678A (ja) 薬物特異的送達用カプセル及びその調製方法
WO2010065492A1 (en) Alpha2-adrenergic agonist a calcium channel blocker composition
JP5256739B2 (ja) ビンカアルカロイド誘導体の安定固体分散体とその製造方法
CN1717252B (zh) 含有碱性药物的制剂
CN101703512B (zh) 一种复方坦洛新和非那雄胺控释片及制备方法
CN102240273A (zh) 一种兰索拉唑肠溶胶囊的制备方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200522

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200522

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210615

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20210803

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211007

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20211007

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20211116